Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 129

Results For "ether"

1499 News Found

Novo Nordisk expands research collaboration for biologic medicines
Biotech | March 09, 2022

Novo Nordisk expands research collaboration for biologic medicines

This collaboration has resulted in several high-impact scientific publications describing breakthrough inventions, including the SOMA robotic pill, which has subsequently been licensed exclusively to Novo Nordisk for clinical development


Vantage Specialty Chemicals acquires JEEN
News | March 08, 2022

Vantage Specialty Chemicals acquires JEEN

JEEN’s portfolio includes a diverse range of specialized active ingredients, botanical extracts, and complexes serving functional applications for skin and hair care


Cionic’s Neural Sleeve granted USFDA clearance
Medical Device | March 08, 2022

Cionic’s Neural Sleeve granted USFDA clearance

Neural sleeve first algorithm-powered bionic garment designed to help those with mobility issues due to multiple sclerosis, stroke, cerebral palsy, and other conditions, regain functional movement in everyday activities


Arctoris and Evariste Technologies form JV to treat non-small cell lung cancer
Biotech | March 07, 2022

Arctoris and Evariste Technologies form JV to treat non-small cell lung cancer

Arctoris and Evariste Technologies announce a joint venture to develop novel small molecule kinase inhibitors for non-small cell lung cancer (NSCLC)


Known Medicine partners with Duke University to predict lung cancer response to drug treatments
Biotech | March 04, 2022

Known Medicine partners with Duke University to predict lung cancer response to drug treatments

Collaboration aims to capture patient-to-patient variability to determine the best treatment for every cancer


Cipla gets approval from SEC to conduct Paxlovid trials
News | March 03, 2022

Cipla gets approval from SEC to conduct Paxlovid trials

Paxlovid consists of nirmatrelvir, which inhibits a SARS-CoV-2 protein to stop the virus from replicating, and ritonavir, which slows down nirmatrelvir’s breakdown to help it remain in the body for a longer period at higher concentrations


Medix Biochemica announces expansion of its porfolio
Biotech | March 03, 2022

Medix Biochemica announces expansion of its porfolio

The accelerated growth of Medix Biochemica will establish its status as the ultimate IVD raw materials supplier


Merck KGaA reports higher profits on strong volumes across its businesses
News | March 03, 2022

Merck KGaA reports higher profits on strong volumes across its businesses

Company expects strong organic growth in sales, EBITDA in 2022


Diversification by pharma companies critical to repositioning supply chain
News | March 02, 2022

Diversification by pharma companies critical to repositioning supply chain

Technology adoption helped the industry to sail through Covid-19 disruption as it understood the need to digitize, learn, and excel


USFDA approves first generic version of Apokyn cartridges
Drug Approval | March 02, 2022

USFDA approves first generic version of Apokyn cartridges

TruPharma has commenced commercial marketing of Sage's approved generic cartridge product